Engineering peroxygenases for pharmaceutical applications: recent advances and future perspectives.
- 1Lehrstuhl für Biotechnologie, RWTH Aachen University Worringerweg 3 52074 Aachen Germany [email protected] [email protected].
Abstract
Selective oxidation is a cornerstone process in pharmaceutical biosynthesis, as it enables the conversion of inert C-H bonds into valuable functional groups such as alcohols, ketones, epoxides, and carboxylic acids, which serve as important intermediates in drug synthesis. Peroxygenases, including unspecific peroxygenases and P450 peroxygenases, have emerged as powerful biocatalysts for enzymatic oxidation, with growing applications in metabolite synthesis, late-stage C-H functionalization, and the preparation of enantioenriched intermediates for pharmaceutical development. In this review, we present the latest advances in peroxygenases engineering for pharmaceutical applications. We summarize pharmaceutical drug candidates that can serve as substrates for peroxygenases, discuss the enzymatic oxidation pathways mediated by peroxygenases for these substrates, and outline protein engineering strategies employed to improve the catalytic performance and properties of peroxygenases in pharmaceutical biosynthesis. We also discuss the potential of emerging artificial intelligence (AI) strategies for multi-dimensional peroxygenase engineering including catalytic activity, thermostability, hydrogen peroxide tolerance, heterologous expression, substrate scope, regioselectivity, and enantioselectivity. Overall, continued progress in peroxygenase engineering will drive the transformation of these biocatalysts for versatile industrial applications, thereby enabling sustainable drug synthesis, efficient metabolite production, and innovative therapeutic strategies.
Related
- Pharmaceutical Applications of Nucleic Acid Aptamers: Recent Advances and Future Perspectives in Therapeutics, Biosensing, Bioanalysis, and Process Analysis
- Metal-Based Anticancer Drugs: Integrating Pharmaceutical Perspectives with DFT-Based Quantum Chemical Topology (QTAIM and ELF)
- New Advances in Bioactive Compounds in Health and Disease: From Molecular Mechanisms to Translational Perspectives
- Genome Editing for Earliness and Plant Architecture in Cucurbit Crops: Recent Advances and Future Perspectives
- Advances and Future Perspectives on Chitosan-Based Hydrogels for Bone Regeneration in Periodontitis-Associated Defects
BibTeX
@article{feng2026engineering,
title = {{Engineering peroxygenases for pharmaceutical applications: recent advances and future perspectives.}},
author = {Lilin Feng and Atul Kumar and Ulrich Schwaneberg and Marisa Sárria Pereira de Passos},
journal = {Chemical science},
year = {2026},
month = oct,
doi = {10.1039/d6sc04536g},
url = {https://europepmc.org/article/MED/42871558},
note = {CC BY},
}
RIS
TY - JOUR
TI - Engineering peroxygenases for pharmaceutical applications: recent advances and future perspectives.
AU - Lilin Feng
AU - Atul Kumar
AU - Ulrich Schwaneberg
AU - Marisa Sárria Pereira de Passos
PY - 2026
DA - 2026/10/13
JO - Chemical science
DO - 10.1039/d6sc04536g
UR - https://europepmc.org/article/MED/42871558
AB - Selective oxidation is a cornerstone process in pharmaceutical biosynthesis, as it enables the conversion of inert C-H bonds into valuable functional groups such as alcohols, ketones, epoxides, and carboxylic acids, which serve as important intermediates in drug synthesis. Peroxygenases, including unspecific peroxygenases and P450 peroxygenases, have emerged as powerful biocatalysts for enzymatic oxidation, with growing applications in metabolite synthesis, late-stage C-H functionalization, and the preparation of enantioenriched intermediates for pharmaceutical development. In this review, we present the latest advances in peroxygenases engineering for pharmaceutical applications. We summarize pharmaceutical drug candidates that can serve as substrates for peroxygenases, discuss the enzymatic oxidation pathways mediated by peroxygenases for these substrates, and outline protein engineering strategies employed to improve the catalytic performance and properties of peroxygenases in pharmaceutical biosynthesis. We also discuss the potential of emerging artificial intelligence (AI) strategies for multi-dimensional peroxygenase engineering including catalytic activity, thermostability, hydrogen peroxide tolerance, heterologous expression, substrate scope, regioselectivity, and enantioselectivity. Overall, continued progress in peroxygenase engineering will drive the transformation of these biocatalysts for versatile industrial applications, thereby enabling sustainable drug synthesis, efficient metabolite production, and innovative therapeutic strategies.
SN - 2041-6520
SN - 2041-6539
ER -